![Julia Neugebauer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julia Neugebauer
Verksamhetschef på
VIVORYON THERAPEUTICS N.V.
Förmögenhet: - $ per 2026-06-30
Profil
Julia Neugebauer currently works at Vivoryon Therapeutics NV, as Chief Operating Officer & Executive Director from 2025.
Dr. Neugebauer also formerly worked at MorphoSys AG, as Senior Director-Investor Relations from 2020 to 2022.
Dr. Neugebauer received her doctorate degree from Ludwig-Maximilians-Universität München.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-17 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av Julia Neugebauer
| Företag | Position | Start |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Verksamhetschef | 2025-05-01 |
Tidigare kända positioner av Julia Neugebauer
| Företag | Position | Slut |
|---|---|---|
| MORPHOSYS AG | Investor Relations Kontakt | - |
Julia Neugebauers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
1
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
